Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 3 (2006), Issue 7 (July)

1. Selectively increased oxidative modifications mapped to detergent-insoluble forms of Abeta and beta-III tubulin in Alzheimer's disease.
   FASEB J, 20(9): 1473-83. [Abstract] [Full-text]
2. Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms.
   FASEB J, 20(9): 1431-42. [Abstract] [Full-text]
3. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.
   FASEB J, 20(9): 1369-76. [Abstract] [Full-text]
4. Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome.
   FASEB J, 20(9): 1361-8. [Abstract] [Full-text]
5. Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin.
   J Mol Biol, 360(2): 251-7. [Abstract] [Full-text]
6. Synapse formation and function is modulated by the amyloid precursor protein.
   J Neurosci, 26(27): 7212-21. [Abstract] [Full-text]
7. Age of acquisition affects object recognition and naming in patients with Alzheimer's disease.
   J Clin Exp Neuropsychol, 28(6): 1010-22. [Abstract] [Full-text]
8. Retrograde amnesia for autobiographical memories and public events in mild and moderate Alzheimer's disease.
   J Clin Exp Neuropsychol, 28(6): 914-27. [Abstract] [Full-text]
9. Object perception impairments predict instrumental activities of daily living dependence in Alzheimer's disease.
   J Clin Exp Neuropsychol, 28(6): 884-97. [Abstract] [Full-text]
10. The Placing Test: preliminary investigations of a quick and simple memory test designed to be sensitive to pre-dementia Alzheimer's disease but not to normal ageing.
    J Clin Exp Neuropsychol, 28(6): 843-58. [Abstract] [Full-text]
11. The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease.
    J Biol Chem, 281(28): 19296-304. [Abstract] [Full-text]
12. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.
    Neurology, 67(1): 76-82. [Abstract] [Full-text]
13. Elevated cortical zinc in Alzheimer disease.
    Neurology, 67(1): 69-75. [Abstract] [Full-text]
14. Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease.
    Neurology, 67(1): 64-8. [Abstract] [Full-text]
15. Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.
    Neurology, 67(1): 57-63. [Abstract] [Full-text]
16. Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice.
    J Pharmacol Exp Ther, 318(2): 571-8. [Abstract] [Full-text]
17. Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide.
    J Pharmacol Exp Ther, 318(2): 855-62. [Abstract] [Full-text]
18. Distinguishing between vascular dementia and Alzheimer's disease by means of the WAIS: a meta-analysis.
    J Clin Exp Neuropsychol, 28(7): 1158-75. [Abstract] [Full-text]
19. Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1.
    Exp Cell Res, 312(13): 2592-604. [Abstract] [Full-text]
20. Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease.
    Neurosci Lett, 404(1): 217-21. [Abstract] [Full-text]
21. Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients.
    Neurobiol Aging, 27(9): 1193-201. [Abstract] [Full-text]
22. Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease.
    Neurobiol Aging, 27(9): 1212-5. [Abstract] [Full-text]
23. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Neurobiol Aging, 27(9): 1216-23. [Abstract] [Full-text]
24. Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample.
    Neurobiol Aging, 27(9): 1202-11. [Abstract] [Full-text]
25. Alzheimer's disease.
    Lancet, 368(9533): 387-403. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.